Effects of a β3-Adrenergic Agonist on Glucose Uptake and Leptin Expression and Secretion in Cultured Adipocytes from Lean and Overweight (Cafeteria) Rats
- 1 March 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 291 (5) , 1201-1207
- https://doi.org/10.1006/bbrc.2002.6577
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effects of Trecadrine®, a β3-adrenergic agonist, on leptin secretion, glucose and lipid metabolism in isolated rat adipocytesInternational Journal of Obesity, 2002
- Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPARγ and aP2 genes in adipose tissue: possible features of the antiobesity effects of a β3-adrenergic agonist 1 1Abbreviations: AP2, adipocyte specific fatty acid binding protein; BAT, brown adipose tissue; DIO, diet-induced obesity; HFD, high-fat diet; PPARγ, peroxisome proliferator-activated receptor gamma; RXRα, retinoid X receptor alpha; RARα, retinoid acid receptor alpha; UCP, uncoupling protein; WAT, white adipose tissue; RT-PCR, reverse transcription-polymerase chain reaction; M-MLV, Moloney-Murine Leukemia Virus.Biochemical Pharmacology, 2001
- Transcriptional Regulation of the Leptin Promoter by Insulin-Stimulated Glucose Metabolism in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 2001
- Synergism between insulin and low concentrations of isoproterenol in the stimulation of leptin release by cultured human adipose tissueMetabolism, 2000
- Up-regulation of muscle UCP2 gene expression by a new β3-adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but down-regulation in lean animalsInternational Journal of Obesity, 2000
- β 3 -Adrenergic regulation of leptin, food intake, and adiposity is impaired with agePflügers Archiv - European Journal of Physiology, 1999
- A b3-adrenergic agonist increases muscle GLUT1/GLUT4 ratio, and regulates liver glucose utilization in diabetic rats*Diabetes, Obesity and Metabolism, 1999
- Improvement of metabolic disorders and visceral fat obesity by the β3-adrenoceptor agonist ( hydrobromide (BRL35135A) in genetically obese rodentsBiochemical Pharmacology, 1996
- Potential anti-diabetic applications of a new molecule with affinity for β3-AdrenoceptorsLife Sciences, 1996
- Augmented Expression of the obese Gene in the Adipose Tissue from Rats Fed High-Fat DietBiochemical and Biophysical Research Communications, 1995